Prognostic impact of age and gender in 897 untreated patients with primary myelodysplastic syndromes.
about
Some aspects of allogeneic stem cell transplantation in patients with myelodysplastic syndrome: advances and controversyMDS prognostic scoring systems – past, present, and futureIncreased plasma thrombopoietin levels in patients with myelodysplastic syndrome: a reliable marker for a benign subset of bone marrow failure.Differential response to hypomethylating agents based on sex: a report on behalf of the MDS Clinical Research Consortium (MDS CRC).Myelodysplastic syndromes: diagnosis, prognosis, and treatment.Role and timing of hematopoietic cell transplantation for myelodysplastic syndrome.Revised international prognostic scoring system for myelodysplastic syndromes.Influence of Prognostic Factors on OverallSurvival in Myelodysplastic Syndromes.Comorbidity as a prognostic variable in multiple myeloma: comparative evaluation of common comorbidity scores and use of a novel MM-comorbidity scoreIncreased CDA expression/activity in males contributes to decreased cytidine analog half-life and likely contributes to worse outcomes with 5-azacytidine or decitabine therapyRisk factors for MDS and acute leukemia following total therapy 2 and 3 for multiple myeloma.TP53 mutation variant allele frequency is a potential predictor for clinical outcome of patients with lower-risk myelodysplastic syndromes.Prognostic markers for myeloid neoplasms: a comparative review of the literature and goals for future investigation.Features of Japanese patients with myelodysplastic syndrome in an aging population of Sado Island.Myelodysplastic Syndromes in the Elderly: Treatment Options and Personalized Management.In patients with myelodysplastic syndromes with del(5q), factors other than age and sex contribute to the prognostic advantage, which diminishes over time.The impact of age on the diagnosis and therapy of myelodysplastic syndromes: results from a retrospective multicenter analysis in Germany.10th anniversary of the Austrian MDS Platform: aims and ongoing projects.Validation of the revised international prognostic scoring system (IPSS-R) in patients with lower-risk myelodysplastic syndromes: a report from the prospective European LeukaemiaNet MDS (EUMDS) registry.Clinical Features and Outcomes of 666 Cases with Therapy-Related Myelodysplastic Syndrome (t-MDS).Proposed score for survival of patients with myelodysplastic syndromes.Application of the revised International Prognostic Scoring System for myelodysplastic syndromes in Argentinean patients.Sex disparity in childhood and young adult acute myeloid leukemia (AML) survival: Evidence from US population data.
P2860
Q27010653-F9B4FCD1-22D3-48E5-9E75-9EAA60F40B57Q28082460-C01F4304-3CA6-42EC-B3CF-586CB369C2E0Q33405829-75A21E3A-6399-4FF7-AEF7-F8A668A56B13Q33573681-9428ED54-BE9D-42F8-B3EC-7B1B549AC789Q34389508-0091D6BD-CA88-449F-9922-7CEDF309E412Q34549306-E132D1E1-99CC-494C-A901-1DE06ACEAB58Q34639717-53F8330D-D141-4F3B-BCC6-5D4148AB24E6Q34748960-45CD93AE-94EE-4F32-A9FD-7CF27F80195BQ35664302-19F8FC10-9A52-4987-B14C-9D1ACC76BBB3Q36625233-C09F9430-E310-4037-9E10-A0107CD0FDC5Q36907852-9307EF6F-B4A6-49CA-8697-0FF33F9DDFF9Q37392696-CA878BBD-F939-4B25-84C1-5216765B6241Q37817621-95B7C5D2-BC26-4272-8643-980C196B57CBQ39648553-C1EEC945-21E3-4140-B88A-AB39B9CDDF10Q40420210-FCB26303-AC22-4980-B21E-CCB07E6D7D91Q41748682-688EF180-4758-40A3-A2F6-B120AF1F487EQ44895438-DDE18C48-B05C-406D-8102-01F8F56D8F7FQ48059034-5584D969-5B18-4862-AA4C-92FEE75DEE7CQ49093244-E2DB4DE7-7A02-4461-8E5B-E78649ACB1B6Q49338306-C9534306-AAED-4712-880D-E9E75D2755D4Q50717261-1407FA59-7B3C-40AF-A462-84A404B725C4Q53106171-C3763A0B-F951-411D-8165-2E0F79F1A28FQ55163802-E603EF30-6528-4F20-AD83-4F5A83C2AEBE
P2860
Prognostic impact of age and gender in 897 untreated patients with primary myelodysplastic syndromes.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh-hant
name
Prognostic impact of age and g ...... ary myelodysplastic syndromes.
@en
Prognostic impact of age and g ...... ary myelodysplastic syndromes.
@nl
type
label
Prognostic impact of age and g ...... ary myelodysplastic syndromes.
@en
Prognostic impact of age and g ...... ary myelodysplastic syndromes.
@nl
prefLabel
Prognostic impact of age and g ...... ary myelodysplastic syndromes.
@en
Prognostic impact of age and g ...... ary myelodysplastic syndromes.
@nl
P2093
P2860
P356
P1433
P1476
Prognostic impact of age and g ...... mary myelodysplastic syndromes
@en
P2093
A Giagounidis
M Pfeilstöcker
T Nösslinger
P2860
P304
P356
10.1093/ANNONC/MDP264
P50
P577
2009-07-15T00:00:00Z